You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The partners will use ReviveMed's AI-driven platform to better understand mechanisms of immunotherapy response and resistance in cancer patients.
In Cell this week: proteomic and metabolomic analysis of blood from COVID-19 patients, change in phosphorylation with infection, and more.
In Cell this week: catalog of structural variants within the human genome, proteomic and metabolomic profiles of COVID-19 patients' blood, and more.
A method called microbiome-derived metabolism screening highlighted drug alterations after exposure to personalized gut microbe collections.
In PNAS this week: autosomal genes commonly affected by loss-of-function variants, variants implicated in testis development disorders, and more.
Researchers saw a shift toward lower gut bifidobacterial levels and a dip in pro-inflammatory Th17 immune cells due to ketone bodies production.
In PNAS this week: analysis of 1,200 high-coverage Samoan genome sequences, metabolites associated with frailty among the elderly, and more.
If the results are validated, investigators believe the method could help diagnose patients without the need for a needle biopsy and with fewer false positives.
Multi-omics approaches can give insight into the gut microbiome and more, but there are still challenges to address, speakers at the ABRF meeting said.
The Economist reports that it is increasingly easier to analyze the metabolites people give off, potentially revealing personal information about them.
The Los Angeles Times reports that experts say Moderna's investigational COVID-19 vaccine results seem to be a step in the right direction, but that more testing is needed.
The Washington Post reports a new coronavirus data reporting protocol goes around the Centers for Disease Control and Prevention.
The Trump Administration has reversed its policy that could have stripped international students of their visas, the New York Times says.